![]() |
|
|
Vol. 297, Issue 2, 666-671, May 2001
Pharmacology Research, R&D, Kissei Pharmaceutical Co., Ltd.,
Nagano, Japan (M.K., K.T., S.M., M.K., M.A.); Department of
Pharmacology, Fukuoka Dental College, Fukuoka, Japan (K.K.); and
Department of Obstetrics and Gynecology, Fukuoka University School of
Medicine, Fukuoka, Japan (Y.I., T.K.)
The aim of the present study was to evaluate the efficacy and
2-adrenoceptor (AR) selectivity of KUR-1246, a new uterine relaxant.
Inhibition of spontaneous or drug-induced uterine contractions by
KUR-1246 was evaluated in pregnant rats and rabbits by an organ bath
method or by a balloon method. The selectivity of KUR-1246 was assessed
simultaneously in organs isolated from late-pregnant rats. The affinity
of KUR-1246 for human
1-,
2-, and
3-ARs was determined using
two radioligands. KUR-1246 suppressed both spontaneous and drug-induced
contractions in isolated uteri, the rank order of potency being
isoproterenol > KUR-1246 > terbutaline > ritodrine.
ICI-118551 (selective
2-AR antagonist) competitively antagonized the
KUR-1246-induced inhibition of spontaneous uterine contractions, but
CGP-20712A (selective
1-AR antagonist) and SR-58894A (selective
3-AR antagonist) did not. All
-AR agonists tested produced
significant inhibition of spontaneous uterine contractions in vivo:
ED30 value for KUR-1246 was 0.13 µg/kg/min, a potency
about 6 times and 400 times greater than that of terbutaline and
ritodrine, respectively. In contrast, the positive chronotropic effect
was minimal in KUR-1246-treated rats. KUR-1246 displaced radioligand
binding to
1-,
2-, and
3-ARs, the
pKi values being 5.75 ± 0.03, 7.59 ± 0.08, and 4.75 ± 0.03 for
1-,
2-, and
3-ARs, respectively. For the selectivity of KUR-1246 for human
2-AR, we obtained values of 39.2 ([IC50 for
1-AR]/[IC50 for
2-AR]) and 198.2 ([IC50 for
3-AR]/[IC50 for
2-AR]),
indicating an apparently higher affinity for human
2-AR than for
other
-AR subtypes. The present study clearly demonstrated that
KUR-1246 is a more selective
2-AR agonist than the drugs presently
used for relaxing uterine muscle.